The state of the renin-angiotensin-aldosterone system in patients with the neuroendocrine-metabolic form of the hypothalamic syndrome.
Slavnov
V N
VN
Kiev Scientific Research Institute of Endocrinology and Metabolism.
Markov
V V
VV
Rudichenko
V M
VM
Luchitskii
E V
EV
Oleinik
V A
VA
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000097:blood; D015259:Dopamine Agents / Q000627:therapeutic use; D005665:Furosemide; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced; D007027:Hypothalamic Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D007328:Insulin / Q000097:blood; D008875:Middle Aged; D009490:Neurosecretory Systems / Q000378:metabolism / Q000503:physiopathology*; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000502:physiology*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013577:Syndrome
D015259:Dopamine Agents; D007328:Insulin; D012702:Serotonin Antagonists; D000804:Angiotensin II; D000450:Aldosterone; D005665:Furosemide; D012083:Renin